Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210031524 210013802 1.66 69.3 Curative (C) 2016-01-17 2016-09-18 CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine N N 210029535 ICE-R
210031525 210013807 1.68 50 Curative (C) 2015-01-29 2015-10-06 Bevacizumab + Irinotecan N null 210029666 CYCLO + FLUDARABINE + RITUXIMAB
210031526 210013812 null 55 Curative (C) 2016-02-25 2016-03-25 CLARITY Trial 02 N 210030019 PENTOSTATIN + RITUXIMAB
210031527 210022624 1.72 0 Disease modification (D) 2018-05-21 2018-06-25 Alemtuzumab + Cyclophos TBI Allo null N 210030225 OFATUMUMAB
210031528 210022626 1.75 81.8 Curative (C) 2018-06-28 2018-06-28 Packer Maintenance Regimen 02 null 210030276 BORTEZOMIB + PANOBINOSTAT
210031529 210013816 1.83 87.6 Curative (C) 2019-04-27 2019-04-30 CLL210 TRIAL N N 210030452 CAPECITABINE
210031530 210028196 null 45.3 Curative (C) 2018-09-15 2018-09-15 CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE 02 N 210030490 CARBOPLATIN + PROCARBAZINE
210031531 210013817 0 52.3 null 2018-10-24 2018-10-28 CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE 2 N 210030551 ALL INDUCTION
210031532 210013821 1.64 69 Curative (C) 2013-09-14 2014-10-03 Nilotinib N N 210030605 LENALIDOMIDE
210031533 210013824 1.63 35.5 Curative (C) 2017-10-05 2017-10-12 CVP 2 N 210030823 CYTARABINE
210031534 210013825 1.62 null Disease modification (D) 2016-04-04 2016-04-04 BR14 TRIAL N N 210030851 CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE
210031535 210013828 1.89 63 Disease modification (D) 2017-07-02 2017-07-14 TRASTUZUMAB N N 210030882 CYTARABINE HD + METHOTREXATE HD
210031536 210022635 0 98.6 Curative (C) 2016-05-18 2016-08-11 CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE 02 N 210031032 ABIRATERONE
210031537 210028200 null 75.3 Curative (C) 2017-04-21 2017-04-25 Mitomycin Intravesical 2 N 210031092 UKALL 60+ TRIAL
210031538 210013835 0 77 Curative (C) 2016-11-23 2016-12-28 Mini BEAM 02 N 210031093 ALL MAINTENANCE
210031539 210013840 1.6 87.9 Curative (C) null 2017-03-30 FLUOROURACIL 2 N 210031205 ALL INTENSIFICATION MTX
210031540 210013844 1.78 79.4 Palliative (P) 2018-07-18 2018-08-07 Fludarabine oral 02 N 210031222 CYCLET
210031541 210031578 1.68 12.2 Palliative (P) 2016-04-29 2016-06-08 PACLITAXEL 2 N 210031222 IDARUBICIN
210031542 210013845 null 15 Curative (C) 2017-07-25 2018-04-28 CYTARABINE + ETOPOSIDE 2 null 210031422 CLARITY TRIAL
210031543 210022642 0 75.6 Disease modification (D) 2017-05-18 2017-06-06 Docetaxel 75mg/m2 (21 day) N N 210031422 OFATUMUMAB
210031544 210013846 1.5 82.3 Not known (9) null 2019-09-14 FCR IV - Cycle 2 onwards Y N 210031442 CYCLO + FLUDARABINE + RITUXIMAB
210031545 210022645 1.68 66.7 Curative (C) 2016-12-06 2016-12-13 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE N N 210031596 AML19 TRIAL
210031546 210013854 null null Curative (C) null 2016-05-04 TAMIGA trial N null 210031768 CARBOPLATIN + PACLITAXEL
210031547 210022649 1.77 91.8 Curative (C) 2017-09-19 2017-12-26 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N N 210031869 BORTEZOMIB + PANOBINOSTAT
210031548 210022652 null 69.95 Curative (C) null 2017-04-10 NHL 2003 Gp C M2 & 4 2 null 210032099 NILOTINIB
210031549 210013864 1.61 null Disease modification (D) 2018-01-07 2018-03-03 Nilotinib N null 210032185 DHAP
210031550 210013865 1.73 82.3 Curative (C) 2015-06-01 2015-06-01 FLUDARABINE 02 N 210032314 GEMCARBO
210031551 210013869 null 64.8 Curative (C) null 2019-01-27 Docetaxel 75mg/m2 (21 day) N N 210032409 UKALL 60+ TRIAL
210031552 210022656 1.08 73.1 Disease modification (D) 2019-04-21 2019-04-29 CARBOPLATIN + ETOPOSIDE + THIOTEPA Y N 210032604 ALL MAINTENANCE
210031553 210013875 1.71 82.3 Disease modification (D) 2016-09-16 2016-09-16 Trastuzumab Subcutaneous null N 210032710 ALL MAINTENANCE
210031554 210013877 1.6 53 Curative (C) 2018-01-29 2018-01-29 Bevacizumab + LOMUSTINE N Y 210032994 DOCETAXEL
210031555 210028217 1.77 76 Curative (C) 2017-09-21 2017-10-13 GEMCITABINE N Y 210033021 ALL INDUCTION
210031556 210028217 1.83 112.8 Curative (C) 2006-05-22 2017-07-26 Cytarabine Intrathecal (any age) N Y 210033021 MITOMYCIN
210031557 210013880 null 60.8 Curative (C) 2016-06-01 2016-06-12 CYTARABINE 02 N 210033199 MITOMYCIN
210031558 210013888 1.85 98.9 Curative (C) 2018-07-26 2018-08-25 CLL210 TRIAL N N 210033602 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE
210031559 210022667 1.53 null Curative (C) 2019-06-17 2019-06-22 Gemcitabine weekly 02 N 210033677 FLUDARABINE
210031560 210013895 null 46 Disease modification (D) 2017-10-03 2017-12-05 FLUDARABINE + MELPHALAN N null 210033710 CTD
210031561 210013896 null 105.9 Curative (C) 2017-06-30 2017-07-11 NHL 2003 Gp C M3 02 N 210033781 CAPECITABINE
210031562 210013899 1.84 98 Disease modification (D) 2019-01-10 2019-01-10 Lenalidomide 25mg (Cycle 1 to 25) N N 210033837 CYTARABINE + ETOPOSIDE
210031563 210013902 1.66 64.1 Curative (C) 2018-08-07 2018-08-08 Packer Maintenance Regimen N Y 210033864 CYTARABINE INTRATHECAL
210031564 210013911 1.9 89 null 2019-11-09 2019-11-09 Nilotinib N N 210034315 MELPHALAN
210031565 210013915 1.62 70.8 Curative (C) 2013-02-25 2016-05-18 Cytarabine intrathecal N N 210034385 BOSUTINIB
210031566 210013917 1.72 30.2 Disease modification (D) 2018-12-01 2018-12-31 CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE N N 210034391 CYCLOPHOSPHAMIDE HIGH DOSE
210031567 210013922 0 61 Neo-adjuvant (N) 2015-08-08 2015-09-15 Mitomycin Intravesical 02 null 210034650 IVAC
210031568 210013923 1.62 39.1 Disease modification (D) null 2018-04-26 AML18 PILOT TRIAL N N 210034878 ALL MAINTENANCE
210031569 210028230 1.6 64.3 Curative (C) 2015-04-16 2015-05-01 Abiraterone 2 N 210034999 CVD
210031570 210013926 null null Disease modification (D) 2016-04-25 2016-05-10 Dactinomycin + Vincristine N null 210035018 NILOTINIB
210031571 210013929 1.77 26.6 null 2018-02-09 2018-05-04 Fludarabine IV 2 N 210035201 HYDROXYCARBAMIDE
210031572 210013936 1.78 54 Palliative (P) 2019-02-19 2019-03-27 DAUNORUBICIN + VINCRISTINE 2 N 210035396 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
210031573 210033722 1.8 64 Curative (C) 2017-04-18 2017-07-26 Nilotinib N N 210035468 CYCLO + FLUDARABINE + RITUXIMAB